Literature DB >> 21340166

Aggressive prolactinoma in a child related to germline mutation in the ARYL hydrocarbon receptor interacting protein (AIP) gene.

Luciana Ansaneli Naves1, Marie-Lise Jaffrain-Rea, Sergio Alberto Cunha Vêncio, Clausmir Zaneti Jacomini, Luiz Augusto Casulari, Adrian F Daly, Albert Beckers.   

Abstract

The objective of this study was to describe a familial screening for AIP mutations in the context of aggressive prolactinoma in childhood. A 12-year-old boy, presented headaches and bilateral hemianopsia. He had adequate height and weight for his age (50(th) percentile), Tanner stage G1 P1. His bone age was 10 years. Prolactin was 10.560 ng/mL (3-25), FSH and LH were undetectable, IGF-1, TSH, Free T4, ACTH, and cortisol were within normal ranges. MRI showed a pituitary macroadenoma, 5.3 X 4.0 X 3.5 cm with compression of the optic chiasm, bilateral cavernous sinus invasion, encasement of carotids, and extension to clivus. Surgical debulking was performed. Resistance to cabergoline was characterized and he was submitted to two surgeries and radiotherapy. Immunohistochemical evaluation included prolactin, ACTH, GH, FSH, LH,AIP, c-erb B2, Ki-67, and p53. Genomic DNA was isolated from the index case and 48 relatives, PCR and sequencing were performed.A germline A195V mutation in AIP was identified in the index case and in five asymptomatic relatives. Germline mutations in the AIP gene may be involved in the predisposition to pituitary adenoma formation, as cause or co-factor in pathogenesis of aggressive tumors in young patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21340166     DOI: 10.1590/s0004-27302010000800017

Source DB:  PubMed          Journal:  Arq Bras Endocrinol Metabol        ISSN: 0004-2730


  7 in total

1.  Prospective, long-term study of the effect of cabergoline on valvular status in patients with prolactinoma and idiopathic hyperprolactinemia.

Authors:  Laurent Vroonen; Patrizio Lancellotti; Monica Tomé Garcia; Raluca Dulgheru; Matilde Rubio-Almanza; Ibrahima Maiga; Julien Magne; Patrick Petrossians; Renata Auriemma; Adrian F Daly; Albert Beckers
Journal:  Endocrine       Date:  2016-10-05       Impact factor: 3.633

Review 2.  Acromegaly: clinical features at diagnosis.

Authors:  Lucio Vilar; Clarice Freitas Vilar; Ruy Lyra; Raissa Lyra; Luciana A Naves
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

3.  Familial isolated pituitary adenoma caused by a Aip gene mutation not described before in a family context.

Authors:  J A García-Arnés; I González-Molero; J Oriola; N Mazuecos; R Luque; J Castaño; M A Arraez
Journal:  Endocr Pathol       Date:  2013-12       Impact factor: 3.943

Review 4.  Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene.

Authors:  Albert Beckers; Lauri A Aaltonen; Adrian F Daly; Auli Karhu
Journal:  Endocr Rev       Date:  2013-01-31       Impact factor: 19.871

5.  SNPs in the aryl hydrocarbon receptor-interacting protein gene associated with sporadic non-functioning pituitary adenoma.

Authors:  Yeshuai Hu; Jun Yang; Yongkai Chang; Shunchang Ma; Jianfa Qi
Journal:  Exp Ther Med       Date:  2016-01-18       Impact factor: 2.447

6.  Prognostic Value of Invasion, Markers of Proliferation, and Classification of Giant Pituitary Tumors, in a Georeferred Cohort in Brazil of 50 Patients, with a Long-Term Postoperative Follow-Up.

Authors:  Juliano Coelho de Oliveira Zakir; Luiz Augusto Casulari; José Wilson Corrêa Rosa; João Willy Corrêa Rosa; Paulo Andrade de Mello; Albino Verçosa de Magalhães; Luciana Ansaneli Naves
Journal:  Int J Endocrinol       Date:  2016-08-18       Impact factor: 3.257

Review 7.  The Genetics of Pituitary Adenomas.

Authors:  Christina Tatsi; Constantine A Stratakis
Journal:  J Clin Med       Date:  2019-12-21       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.